Ron Benson Mitchell

Ron Benson Mitchell

Auto-generated profile, based on publicly available information

Ron Benson Mitchell

Department of Otolaryngology—Head and Neck Surgery University of Texas Southwestern Medical Center Dallas Texas USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2019 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
RMRon B. Mitchell
Ron B. Mitchell
SASanford M. Archer
Sanford M. Archer
SIStacey L. Ishman
Stacey L. Ishman
RRRichard M. Rosenfeld
Richard M. Rosenfeld
SCSarah Coles
Sarah Coles
LNLorraine C. Nnacheta
Lorraine C. Nnacheta
Objective: This update of a 2011 guideline developed by the American Academy of Otolaryngology–Head and Neck Surgery Foundation provides evidence‐based recommendations on the pre‐, intra‐, and postoperative care and management of children 1 to 18 years of age under consideration for tonsillectomy. Tonsillectomy is defined as a surgical procedure performed with or without adenoidectomy that completely removes the tonsil, including its capsule, by dissecting the peritonsillar space between the tonsil capsule and the muscular wall. Tonsillectomy is one of the most common surgical procedures in the United States, with 289,000 ambulatory procedures performed annually in children <15 years of age based on the most recent published data. This guideline is intended for all clinicians in any setting who interact with children who may be candidates for tonsillectomy.Purpose: The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing children under consideration for tonsillectomy and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to educate clinicians, patients, and/or caregivers regarding the indications for tonsillectomy and the natural history of recurrent throat infections. Additional goals include the following: optimizing the perioperative management of children undergoing tonsillectomy, emphasizing the need for evaluation and intervention in special populations, improving the counseling and education of families who are considering tonsillectomy for their children, highlighting the management options for patients with modifying factors, and reducing inappropriate or unnecessary variations in care. Children aged 1 to 18 years under consideration for tonsillectomy are the target patient for the guideline.For this guideline update, the American Academy of Otolaryngology–Head and Neck Surgery Foundation selected a panel representing the fields of nursing, anesthesiology, consumers, family medicine, infectious disease, otolaryngology–head and neck surgery, pediatrics, and sleep medicine.Key Action Statements: The guideline update group made strong recommendations for the following key action statements (KASs): (1) Clinicians should recommend watchful waiting for recurrent throat infection if there have been <7 episodes in the past year, <5 episodes per year in the past 2 years, or 1 peritonsillar abscess. (2) Clinicians should ask caregivers of children with obstructive sleep‐disordered breathing and tonsillar hypertrophy about comorbid conditions that may improve after tonsillectomy, including growth retardation, poor school performance, enuresis, asthma, and behavioral problems. (3) Before performing tonsillectomy, the clinician should refer children with obstructive sleep‐disordered breathing for polysomnography if they are <2 years of age or if they exhibit any of the following: obesity, Down syndrome, craniofacial abnormalities, neuromuscular disorders, sickle cell disease, or mucopolysaccharidoses. (4) The clinician should advocate for polysomnography prior to tonsillectomy for obstructive sleep‐disordered breathing in children without any of the comorbidities listed in KAS 5 for whom the need for tonsillectomy is uncertain or when there is discordance between the physical examination and the reported severity of oSDB. (5) Clinicians should recommend tonsillectomy for children with obstructive sleep apnea documented by overnight polysomnography. (6) Clinicians should counsel patients and caregivers and explain that obstructive sleep‐disordered breathing may persist or recur after tonsillectomy and may require further management. (7) The clinician should counsel patients and caregivers regarding the importance of managing posttonsillectomy pain as part of the perioperative education process and should reinforce this counseling at the time of surgery with reminders about the need to anticipate, reassess, and adequately treat pain after surgery. (8) Clinicians should arrange for overnight, inpatient monitoring of children after tonsillectomy if they are <3 years old or have severe obstructive sleep apnea (apnea‐hypopnea index ≥10 obstructive events/hour, oxygen saturation nadir <80%, or both). (9) Clinicians should follow up with patients and/or caregivers after tonsillectomy and document in the medical record the presence or absence of bleeding within 24 hours of surgery (primary bleeding) and bleeding occurring later than 24 hours after surgery (secondary bleeding). (10) Clinicians should determine their rate of primary and secondary posttonsillectomy bleeding at least annually.The guideline update group made a strong recommendation against 2 actions: (1) Clinicians should not administer or prescribe perioperative antibiotics to children undergoing tonsillectomy. (2) Clinicians must not administer or prescribe codeine, or any medication containing codeine, after tonsillectomy in children younger than 12 years.The policy level for the recommendation about documenting recurrent throat infection was an option: (1) Clinicians may recommend tonsillectomy for recurrent throat infection with a frequency of at least 7 episodes in the past year, at least 5 episodes per year for 2 years, or at least 3 episodes per year for 3 years with documentation in the medical record for each episode of sore throat and ≥1 of the following: temperature >38.3°C (101°F), cervical adenopathy, tonsillar exudate, or positive test for group A beta‐hemolytic streptococcus.Differences from Prior Guideline: (1) Incorporating new evidence profiles to include the role of patient preferences, confidence in the evidence, differences of opinion, quality improvement opportunities, and any exclusion to which the action statement does not apply. (2) There were 1 new clinical practice guideline, 26 new systematic reviews, and 13 new randomized controlled trials included in the current guideline update. (3) Inclusion of 2 consumer advocates on the guideline update group. (4) Changes to 5 KASs from the original guideline: KAS 1 (Watchful waiting for recurrent throat infection), KAS 3 (Tonsillectomy for recurrent infection with modifying factors), KAS 4 (Tonsillectomy for obstructive sleep‐disordered breathing), KAS 9 (Perioperative pain counseling), and KAS 10 (Perioperative antibiotics). (5) Seven new KASs: KAS 5 (Indications for polysomnography), KAS 6 (Additional recommendations for polysomnography), KAS 7 (Tonsillectomy for obstructive sleep apnea), KAS 12 (Inpatient monitoring for children after tonsillectomy), KAS 13 (Postoperative ibuprofen and acetaminophen), KAS 14 (Postoperative codeine), and KAS 15a (Outcome assessment for bleeding). (6) Addition of an algorithm outlining KASs. (7) Enhanced emphasis on patient and/or caregiver education and shared decision making.

5 February 2019 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
RMRon B. Mitchell
Ron B. Mitchell
SASanford M. Archer
Sanford M. Archer
SIStacey L. Ishman
Stacey L. Ishman
RRRichard M. Rosenfeld
Richard M. Rosenfeld
SCSarah Coles
Sarah Coles
LNLorraine C. Nnacheta
Lorraine C. Nnacheta

30 March 2023 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
JCJolie L. Chang
Jolie L. Chang
AGAndrew N. Goldberg
Andrew N. Goldberg
JAJeremiah A. Alt
Jeremiah A. Alt
AMAlzoubaidi Mohammed
Alzoubaidi Mohammed
LALiza Ashbrook
Liza Ashbrook
IRIlene M. Rosen
Ilene M. Rosen

18 September 2012 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
RMRon B. Mitchell
Ron B. Mitchell
HHHeather M. Hussey
Heather M. Hussey
GSGavin Setzen
Gavin Setzen
IJIan N. Jacobs
Ian N. Jacobs
BNBrian Nussenbaum
Brian Nussenbaum
AMAlbert Merati
Albert Merati
Objective: This clinical consensus statement (CCS) aims to improve care for pediatric and adult patients with a tracheostomy tube. Approaches to tracheostomy care are currently inconsistent among clinicians and between different institutions. The goal is to reduce variations in practice when managing patients with a tracheostomy to minimize complications.Methods: A formal literature search was conducted to identify evidence gaps and refine the scope of this consensus statement. The modified Delphi method was used to refine expert opinion and facilitate a consensus position. Panel members were asked to complete 2 scale‐based surveys addressing different aspects of pediatric and adult tracheostomy care. Each survey was followed by a conference call during which results were presented and statements discussed.Results: The panel achieved consensus on 77 statements; another 39 were dropped because of lack of consensus. Consensus was reached on statements that address initial tracheostomy tube change, management of emergencies and complications, prerequisites for decannulation, management of tube cuffs and communication devices, and specific patient and caregiver education needs.Conclusion: The consensus panel agreed on statements that address the continuum of care, from initial tube management to complications in children and adults with a tracheostomy. The panel also highlighted areas where consensus could not be reached and where more research is needed. This consensus statement should be used by physicians, nurses, and other stakeholders caring for patients with a tracheostomy.

1 February 2015 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
RMRon B. Mitchell
Ron B. Mitchell
SGSuzan Garetz
Suzan Garetz
RMReneé H. Moore
Reneé H. Moore
CRCarol L. Rosen
Carol L. Rosen
CMCarole L. Marcus
Carole L. Marcus
SRSusan Redline
Susan Redline
Obstructive sleep apnea syndrome (OSAS) is a common disorder of breathing during sleep characterized by episodic upper airway obstruction that interferes with normal respiratory gas exchange.1 In addition to a sleep disturbance, there is compelling evidence that pediatric OSAS negatively affects behavior and quality of life (QOL). The most common cause of OSAS in children is adenotonsillar hypertrophy. Consequently, adenotonsillectomy (AT) is the first-line surgical treatment for pediatric OSAS,2,3 with more than 500 000 procedures performed per annum in the United States.4

9 November 2018 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
YKYann‐Fuu Kou
Yann‐Fuu Kou
MSMark Sakai
Mark Sakai
GSGopi B. Shah
Gopi B. Shah
RMRon B. Mitchell
Ron B. Mitchell
RJRomaine F. Johnson
Romaine F. Johnson